Journal: Transfusion Medicine and Hemotherapy
Submission Deadline: May 31, 2026
We encourage researchers, clinicians, and experts to contribute to our upcoming article collection in the journal Transfusion Medicine and Hemotherapy, focused on cutting-edge developments in biomarkers and liquid biopsy technologies. This collection aims to explore how these tools are transforming our understanding of disease pathogenesis and advancing diagnostic precision.
Scope and Themes
This collection will highlight innovative approaches and recent breakthroughs in:
- Biomarkers: Identification, validation, and clinical application in diagnostics and therapy.
- Liquid Biopsy: Techniques for non-invasive sampling and their role in early detection and monitoring.
- Diagnostic Apheresis: Clinical relevance and evolving techniques in therapeutic and diagnostic settings.
- Circulating Tumor Cells (CTCs): Detection methods and their significance in cancer diagnostics and prognosis.
- Epigenetics: Integration of epigenetic markers in liquid biopsy and biomarker discovery.
- Novel Diagnostics: Emerging technologies and methodologies that redefine diagnostic pathways.
Please select the option “Call for Papers: It’s in the Blood – Biomarkers and Liquid Biopsy” when submitting your manuscript and mention this Call for Papers in your cover letter.
Article publication is subject to rigorous peer review in line with the journal's editorial policies. Please refer to our author guidelines for further details about the publication conditions.
Karger Publishers has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.